FACULTAS toimintakyvyn arviointi

Kirjallisuutta

FACULTAS toimintakyvyn arviointi
19.3.2008

Kirjallisuutta

  1. Andersen G, Vestergaard K, Ingeman-Nielsen M, Jensen TS. Incidence of central post-stroke pain. Pain 1995;61:18–93.
  2. Andrasik F, Lipchik GL, Mc Crory DC, Wittrock DA. Outcome measurement in behavioural headache research; headache parameters and psyhcosocial outcomes. Headache 2005;45:429–37.
  3. Arnold LM, Keck PE Jr, Welge JA. Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics 2000;41:104–13.
  4. Attal N, Gruccu G, Haanpää M ym. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006;13:1–17.
  5. Attal N, Cruccu G, Haanpää M ym. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006;13:1153–69.
  6. Ayzenberg I, Obermann M, Nyhuis P ym. Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structures. Cephalalgia 2006;26:1106–14.
  7. Bass C, Murphy M. Somatoform and personality disorders: syndromal comorbidity and overlapping developmental pathways. J Psychosom Res 1995;39:403–427.
  8. Becker N, Sjogren P, Bech P, Olsen AK, Eriksen J.Treatment outcome of chronic non-malignant pain patients managed in a danish multidisciplinary pain centre compared to general practice: a randomised controlled trial. Pain 2000;84:203 –11.
  9. Bendtsen L, Jensen R. Amitriptyline reduces myofascial tenderness in patients with chronic tension-type headache. Cephalalgia 2000;20:603 –10.
  10. Bendtsen L, Jensen R. Mirtatzapine is effective in the prophylactic treatment of chronic tension-type headache. Neurology 2004;62:1706 –11.
  11. Bennett MI, Attal N, Backonja MM ym. Using screening tools to identify neuropathic pain. Pain 2007;127:199–203.
  12. Birklein F, Rowbotham M. Does pain change the brain? Neurology 2005;65:666–7.
  13. Birket-Smith, M. Somatization and chronic pain. Acta Anestesiol. Scan.2001;45:1114–20.
  14. Boersma K, Linton S, J. Early assessment of psychological factors: The Örebro Screening Questionnaire for Pain. Kirjassa: Linton S. J. toim. New avenues for the prevention of pain. Vol I. Amsterdam Elsevier 2002: s. 205–13.
  15. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 2006;10:287–333.
  16. Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire: development and validation. J Rheumatol 1991;18:728–33.
  17. Burckhardt CS. Non-pharmacologic management strategies in fibromyalgia, Rheum Dis Clin North Am 2002;28:291–304.
  18. Burchardt CS, Clark CR, Bennett RM. Fibromyalgia and quality of life: a comparative analysis. J Rheumatol 1993;20:475–9.
  19. Busch A, Schachter CL, Peloso PM ym. Exercise for treating fibromyalgia syndrome. Cochrane Database Syst Rev 2003; 3:CD003786.
  20. Butland RJ, Pang J, Gorss ER, Woodcock AA, Geddas DM. Two-, six-, and 12 minute walking tests in respiratory disease. Br Med J (Clin Res Ed) 1982;284:1607–8.
  21. Cathey MA, Wolfe F, Kleinheksel Functional ability and work status in patients with fibromyalgia. Arthritis Care Res 1988;1:85–98.
  22. Cepeda MS, Carr DB, Lau J. Local anesthetic sympathetic blockade for complex regional pain syndrome. Cochrane Database Syst Rev 2005; 4:CD004598.
  23. Clauw DJ, Crofford LJ. Chronic widespread pain and fibromyalgia: what we know, and what we need to know. Best Pract Res Clin Rheumatol 2003;17:685–701.
  24. Colas R, Munoz P, Temprano R, Gomez C, Pascual J. Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology 2004;62:1338–42.
  25. Cruccu G, Anand P, Attal N ym. EFNS guidelines on neuropathic pain assessment. Eur J Neurol 2004; 11:153–162.
  26. Crofford LJ. Pharmaceutical treatment options for fibromyalgia. Curr Rheumatol Rep 2004;6:274–80.
  27. Croft P, Schollum J, Sillman A. Population study of tender point counts and pain as evidence of fibromyalgia. Br Med J 1994;309:696–9.
  28. Daousi C, MacFarlane IA, Woodward A, Nurmikko TJ, Bundred PE, Benbow SJ. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med 2004;21:976–82.
  29. Davies M, Brophy S, Williams R, Taylor A. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care 2006;29:1518–22.
  30. De Mos M, de Bruijn AG, Huygen FJ, Dieleman JP, Stricker BH, Sturkenboom MC. The incidence of complex regional pain syndrome: a population based study. Pain 2006
  31. Baron R, Jänig W. Complex regional pain syndromes – how do we escape the diagnostic trap? Lancet 2004;364:1739–41.
  32. De Waal MWM, Arnold IA, Eekhof JAH, van Hemert AM. Somatoform disorders in general practice. Prevalence, functional impairment and comorbidity with anxiety and depressive disorders. Br J Psychiatry 2004;184:470–476.
  33. Diener H-C, Katsarava Z. Analgesic/abortive overuse and misuse in chronic daily headache. Curr Pain Headache Rep 2001;5:545–50.
  34. Fairbank JC, Pnsent PB. The Oswestry Disability Index. Spine 2000;25:2940–52.
  35. Finnerup NB, Johannesen IL, Sindrup SH, Bach FW, Jensen TS. Pain and dysesthesia in patients with spinal cord injury: a postal survey. Spinal Cord 2001;39:256–62.
  36. Flor H, Fydrich T, Turk DC. Efficacy of multidisciplinary pain treatment centers: a meta-analytic review. Pain 1992;49:221–30.
  37. Frettlöh J, Hüppe M, Maier C. Severity and specifity of neglect-like symptoms in patients with complex regional pain syndrome (CRPS) compared to chronic limb pain of other origins. Pain 2006;124:184–9.
  38. Freynhagen R, Baron R, Gockel U, Tolle TR. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin 2006; 22: 1911–20.
  39. Fink et al, Psychosomatics 2005;46:540–548
  40. Färkkilä M. Krooninen päivittäinen päänsärky. Duodecim 2005;121:657–63.
  41. Färkkilä M. Päänsärky. Kirjassa: Soinila S, Kaste M, Somer H ym. Neurologia, 2. painos. Duodecim 2006 s. 175–6.
  42. Galil K, Choo PW, Donahue DVM, Platt R. The sequelae of herpes zoster. Arch Intern Med 1997;157:1209–1213.
  43. Goldenberg DL, Burchardt C, Crofford L. Management of fibromyalgia. JAMA 2004;292:2388–95.
  44. Granström V. Psykiatria kipupotilaan tutkimisessa ja hoidossa. Suom Lääkäril 2005;60:3373–7.
  45. Haanpää M, Kivipelto L, Pohjola J ym. Pään alueen neuralgisten kipujen hoito. Duodecim 2005;121:687–95.
  46. Haanpää M. Neuropaattisen kivun hoito-opas. Suomen Kivuntutkimusyhdistys ry 2007 ja Terveysportti.
  47. Hannonen P. Mikä hoidoksi fibromyalgiaan? Suomen Lääkärilehti 2005;37:3625–9.
  48. Hannonen P, Mikkelsson M. M79.0 - mistä fibromyalgiassa on kyse, mitä hoidoksi? Duodecim 2004;120:237–46.
  49. Hansson P, Haanpää M. Diagnostic work-up of neuropathic pain: Computing, using questionnaires or examining the patient? Eur J Pain 2007.
  50. Harke H, Gretenkort P, Ladleif HU, Rahman S. Spinal cord stimulation in sympathetically maintained complex regional pain syndrome type I with severe disability. A prospective clinical trial. Eur J Pain 2005;9:363–373.
  51. Hawley D, Wolfe F. Pain disability and pain/disability relationships in seven rheumatic disorders: a study of 1522 patients. J Rheumatol 1991;18:1552–7.
  52. Headache Classification Subcommittee of the International Classification of Headache Society. The International Classification of Headache Disorders. Cephalalgia 2004; 24 (Suppl 1): 1–160.
  53. Hidding A, van Santen M, de Klerk E ym. Comparison between self-report measures and clinical observations of functional disability in ankylosing spondylitis, rheumatoid arthritis and fibromyalgia. J Rheumatol 1994;21:818–23.
  54. Hiller W, Rief W, Fichter MM. How disabled are patients with somatoform disorders? Gen Hosp Psychiatry 1997;19:432–438.
  55. Hoffman BM, Papas RK, Chatkoff DK, Kerns RD. Meta-analysis of psychological interventions for chronic back pain. Health Psychol 2007;26:10–12.
  56. Holroyd K, O'Donnell F, Stensland M ym. Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy and their combination: a randomized, controlled trial. JAMA 2001;285:2208–15.
  57. Hsu MC, Clauw DJ. A different type of procedure for a different type of pain. Arthritis Rheum 2006;54:3725–7.
  58. Jelinski SE, Magnusson JE, Becker WJ. Factors associated with depression in patients referred to headache specialists. Neurology 2007;68;489–95.
  59. Juottonen K, Gockel M, Silen T, Hurri H, Hari R, Forss N. Altered central sensorimotor processing in patients with complex regional pain syndrome. Pain 2002;98:315–23.
  60. Jänig W, Baron R. Complex regional pain syndrome: mystery explained? Lancet Neurol 2003;2:687–97.
  61. Jääskeläinen S, Haanpää M, Häkkinen V. Kvantitatiiviset tuntokynnysmittaukset. Kirjassa: Partanen J ym. Toim. Kliininen neurofysiologia, Duodecim 2006; s. 600–616.
  62. Jääskeläinen S, Teerijoki-Oksa T, Virtanen A, Tenovuo O, Forssell H. Sensory regeneration following intraoperatively verified trigeminal nerve injury. Neurology 2004;62:1951–7.
  63. Kallela M. Mitä uutta migreenin patofysiologiasta ja genetiikasta? Duodecim. 2005;121:665–73.
  64. Kalso E, Paakkari P, Stenberg I toim. Opioidit pitkäaikaisessa kivussa. Lääkelaitos 2004.
  65. Karjalainen K, Malmivaara A, van Tulder M ym. Multidisciplinary rehabilitation for fibromyalgia and musculoskeletal pain in working age adults. Cochrane Database Syst Rev 2000;(2):CD001984.
  66. Katon WJ, Walker EA. Medically unexplained symptoms in primary care. J Clin Psychiatry 1998;59 Suppl 20:15–21.
  67. Katsarava Z, Muessig M, Dzagnidze A ym. Medication overuse headache: rates and predictors for relapse in a 4-year prospective study. Cephalalgia 2005;25:12–15.
  68. Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet 2006;367:1618–25.
  69. Kemler MA, de Vet HC, Barendse GA, van den Wildenberg FA, van Kleef M. The effect od spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomised controlled trial. Ann Neurol 2004;55:13–8.
  70. Kennedy M, Felson DT A prospective long-term study of fibromyalgia syndrome. Arthritis Rheum 1996;39:682–5.
  71. Kisely S, Campbell LA, Skerrit P. Psychological interventions for symptomatic management of non-spesific chest pain in patients with normal coronary anatomy. Cochrane Database Syst Rev 2005;1: CD 004101.
  72. Kivimäki M, Leino-Arjas P, Kaila-Kangas l ym. Increased absence due to sickness among employees with fibromyalgia. Ann Rheum Dis. 2007;66:65–9.
  73. Koskinen M, Hietaharju A, Kyläniemi M ym. A quantitative method for the assessment of intraepidermal nerve fibers in small-fiber neuropathy. J Neurol 2005;252:789–94.
  74. Lasten päänsäryn Käypä hoito 2003.
  75. Laukkanen RT. Developement and evaluation of a 2-km walking test for assessing maximal aerobic power of adults in field conditions. Kuopion yliopiston julkaisuja D. Lääketiede 23, 1993.
  76. Ledingham J, Doherty S, Doherty M. Primary fibromyalgia syndrome - an outcome study. Br J Rheumatol 1993;32:139–42.
  77. Lindfors N, Kallio P. Lapsen raajakipu – tunnistatko kipuoireyhtymän? Duodecim 2007;123:290–5.
  78. Linton S, Boersma K. Early identification of patients at risk of developing a persistent back problem: the predictive validity of the Orebro Musculoskeletal Pain Questionnaire. Clin J Pain 2003;19:80–6.
  79. Macfarlane GJ, Morris S, Hunt IM ym. Chronic widespread pain in the community: the influence of psychological symptoms and mental disorder on health care seeking behavior. J Rheumatol 1999;26:413–9.
  80. Macfarlane GJ, Thomas E, Papageorgion AC, Schollum J, Croft PR, Silman AJ. The natural history of chronic pain in the community: a better prognosis than in the clinic. J Rheumatol 1996;23:1617–20.
  81. Maihöfner C, Handwerker HO, Neundorfer Birklein F. Cortical reorganization during recovery from complex regional pain syndrome. Neurology 2004;63:693–701.
  82. Mannerkorpi K, Iversen M. Physical exercise in fibromyalgia and related syndromes. Best Pract Res Clin Rheumatol 2003;17:629–47.
  83. Merskey H, Bogduk N toim. Task force on taxonomy of the International Association for the Study of Pain: Classification of chronic pain. Description of pain syndromes and definitions of pain terms. Seattle: IASP Press 1994.
  84. Merskey H, Bogduk N. Task force on taxonomy of the International Association for the Study of Pain: Classification of chronic pain. Description of pain syndromes and definitions of pain terms. Seattle: IASP Press 1994, s. 40–43.
  85. Meyer-Rosberg K, Kvarnstrom A, Kinnman E, Gordh T, Nordfors LO, Kristofferson A. Peripheral neuropathic pain – a multidimensional burden for patients. Eur J Pain. 2001;5(4):379–89.
  86. Migreenin Käypä hoito 2002.
  87. Moore A, Edwards J, Barden J, McQuay H. Bandolier's little book of pain. An evidence-based guide to treatments. Oxford University Press 2003.
  88. Moseley GL. Is successful rehabilitation of complex regional pain syndrome due to sustained attention to the afftected limb? A randomised clinical trial. Pain 205;114:54–61.
  89. Mäntyselkä P, Kumpusalo E, Ahonen R ym. Pain as a reason to visit the doctor: a study in Finnish primary health care. Pain 2001;89:175–80.
  90. Mäntyselkä P, Turunen J, Ahonen R, Kumpusalo E. Chronic pain and poor self-rated health. JAMA 2003;290:2435–42.
  91. Nikiforow Rita Epidemiological studies on headache in northern Finland. Väitöskirja. Oulun yliopisto 1981.
  92. Rasmussen B, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population – a prevalence study. J Clin Epidemiol 1991;44:1147–57.
  93. Paltamaa J, Karppi S-L, Smolander J, Koho P, Vaara M, Hurri H. Suomessa käytössä olevia toimintakyvyn arviointimenetelmiä ja WHO:n uusi toimintakykyluokitus ICF. Suomen Lääkärilehti 2006;61:459–64
  94. Pohjolainen T. Kuntoutuksen vaikuttavuus – mitä se tarkoittaa ja onko näyttöä? Suomen Lääkärilehti 2005;60:3399–3405.
  95. Quimby LG, Block SR, Gratwick GM. Fibromyalgia: generalized pain intolerance and manifold symptom re-porting. J Rheumatol 1988;15:1264–70.
  96. Rains JC, Penzien DB. Sleep and chronic pain: challenges to the alpha-EEG sleep pattern as a pain specific sleep anomaly. J Psychosom Res 2003;54:77–83.
  97. Rao SG, Bennett RM. Pharmacological therapies in fibromyalgia. Best Pract Res Clin Rheumatol 2003;17:611–7.
  98. Rasmussen B, Olesen J. Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia 1992;12:221–8.
  99. Rowbotham MC. Pharmacological management of complex regional pain syndrome. Clin J Pain 2006;22:425–9.
  100. Salokangas RK, Stengård E, Poutanen O. DEPS – uusi väline depression seulontaan. Duodecim 1994; 110, 1141–48.
  101. SBU. Rapporter - Metoder för behandling av långvarig smärta [verkkodokumentti] 2006. www.sbu.se
  102. Smith AG, Russell J, Feldman EL ym. Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care 2006;29:1294–9.
  103. Smith BH, Torrance N, Bennett MI, Lee AJ. Health and quality of life associated with chronic pain of pre-dominantly neuropathic origin in the community. Clin J Pain 2007;23:143–9.
  104. Smolander J, Hurri H ym. Toiminta- ja työkyvyn fyysisten arviointi- ja mittausmenetelmien kartoittaminen ICF-luokituksen aihealueella "liikkuminen". Toiminta- ja työkyvyn edellytyksiä arvioiva testistö– viitekehyksenä WHO:n kansainvälisen toimintakykyluokituksen (ICF) "suoritukset"-osa-alue (ACTIVITIES). Stakes ja Kansaneläkelaitos, Aiheita 25/2004. Helsinki 2004. Saatavissa: www.stakes.fi/verkkojulk/#2004
  105. Taylor RS, van Buyten J, Buchser E. Spinal cord stimulation for complex regional pain syndrome: a systematic review of the clinical and cost-effectiveness literature and assessment of prognostic factors. Eur J Pain 2006;10:91–101.
  106. Stewart WF, Lipton RB, Kolodner KB, Sawyer J, Lee C, Liberman JN. Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain 2000;88:41–52.
  107. Torelli P Jensen R, Olesen J. Physiotherapy for chronic tension-type headache: a controlled study. Cephalalgia 2004;24:29–36.
  108. Treede RD, Jensen TS ym. Neuropathic pain. Redefinition and a grading system for clinical and research purp. Neurology 2007 Nov 14 (Epub ahead of print)
  109. Tuomi K, Ilmarinen J, Jahkola A. Työkykyindeksi. Työterveyslaitos 1997.
  110. Ware JE jr, Shrebourne. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473–83.
  111. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38:19–28.
  112. Wolfe F, Smythe H, Yunus MB ym. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 1990;33:160–72.
  113. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms and management. Lancet 1999;353:1959–64.
  114. Österberg A, Boivie J, Thuomas KA. Central pain in multiple sclerosis – prevalence and clinical characteristics. Eur J Pain 2005;9:531–42.